N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities.
about
CXC chemokine receptor 4 is a cell surface receptor for extracellular ubiquitinSecreted trefoil factor 2 activates the CXCR4 receptor in epithelial and lymphocytic cancer cell linesApoptosis of uninfected cells induced by HIV envelope glycoproteinsStructure/function of human herpesvirus-8 MIP-II (1-71) and the antagonist N-terminal segment (1-10)Structural Basis of CXCR4 Sulfotyrosine Recognition by the Chemokine SDF-1/CXCL12Structure-function relationship between the human chemokine receptor CXCR3 and its ligandsExtracellular ubiquitin: immune modulator and endogenous opponent of damage-associated molecular pattern moleculesMolecular dynamics simulations on SDF-1alpha: binding with CXCR4 receptorThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsIdentification of allosteric peptide agonists of CXCR4.On-column refolding of recombinant chemokines for NMR studies and biological assays.Small neutralizing molecules to inhibit actions of the chemokine CXCL12.Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4.Molecular determinants for CC-chemokine recognition by a poxvirus CC-chemokine inhibitorIdentification and characterization of circulating variants of CXCL12 from human plasma: effects on chemotaxis and mobilization of hematopoietic stem and progenitor cells.The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency.Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entry.Targeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis.The CXC chemokine receptor 4 ligands ubiquitin and stromal cell-derived factor-1α function through distinct receptor interactions.The chemokine stromal cell-derived factor-1 regulates the migration of sensory neuron progenitors.Initial assessment of the role of CXC chemokine receptor 4 after polytrauma.Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).Structural basis of chemokine receptor function--a model for binding affinity and ligand selectivityThe development and characterization of SDF1α-elastin-like-peptide nanoparticles for wound healing.Macrophage Migration Inhibitory Factor-CXCR4 Receptor Interactions: EVIDENCE FOR PARTIAL ALLOSTERIC AGONISM IN COMPARISON WITH CXCL12 CHEMOKINE.Role of CXCR4 internalization in the anti-HIV activity of stromal cell-derived factor-1α probed by a novel synthetically and modularly modified-chemokine analog.Allosteric peptide regulators of chemokine receptors CXCR4 and CXCR7Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors.International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.Effects of exogenous ubiquitin in a polytrauma model with blunt chest trauma.Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases.Chemokine oligomerization in cell signaling and migration.Development of novel CXCR4-based therapeutics.Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4).Significance of CXCL12 in type 2 diabetes mellitus and its associated complications.Characterization of the stromal cell-derived factor-1alpha-heparin complex.Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists.Altered CXCL12 expression reveals a dual role of CXCR4 in osteosarcoma primary tumor growth and metastasis.Cloning and characterization of SDF-1gamma, a novel SDF-1 chemokine transcript with developmentally regulated expression in the nervous system.Internalization of CCR4 and inhibition of chemotaxis by K777, a potent and selective CCR4 antagonist.
P2860
Q24302660-C0FDB393-39F4-4207-813D-1450B13A5FB4Q24323314-52023B8D-2804-49AF-83D5-E20F9EE8D1EEQ24801374-2EB41FD8-3E78-4635-9B49-5C0629AF267EQ27629348-FEF3773E-431B-4EA9-9E63-69DFE3526D35Q27652199-8DC7E578-4969-4923-926D-AAF470157BCFQ28213616-7FA4C720-C996-41A7-9502-7A3D843CFEFFQ28289847-C539B641-61BD-49FA-B373-10CD04B629B3Q30332403-8F6F966C-E10F-4F78-AC35-B89D627AA669Q30486707-3079943A-DA66-46F9-B892-D55AB16D3232Q30868390-95C5B28C-38B5-4CB1-A7C4-2EEEB83AD780Q33261938-59DEB581-AD11-4168-B610-02A140581199Q33343941-2FF6FCB3-BFFE-4011-BEC9-B841248131EBQ33803636-74FF9B6E-D4CE-4E10-8D6B-88A51D1A9293Q33929458-3064D75F-D611-4391-AF58-1505220AE9A4Q33998570-7EA219FC-9E63-45EE-B1DC-99CA4B1DADD5Q34287228-BF3139A3-46BE-451F-94A4-FB12FB4275BCQ34975941-87BF54AF-C873-499E-A883-4B5C1D158DE5Q35213463-F054396A-30F7-4238-94BC-DF34C43DE73DQ35312229-6BB0B89A-7DCC-4CB1-AAE7-7C6B25D4533FQ35704572-C2D0148F-8E98-4A18-AD73-4B0D37C8EC9DQ36327374-A10C30CB-330E-44B0-A57D-D1C59EEF6EFCQ36334083-8F7B6009-6E68-4478-9E09-7DBFF3610387Q36616071-1025DA57-DA08-4FC1-BC76-8882AEA38449Q36973357-082CF9DC-52F3-4459-B297-106810037C6AQ37117350-E4B51D3C-5513-48EF-B303-E7B6FBA7AA9DQ37118537-22853610-65CF-4C90-94C2-C421A43A12F0Q37284295-59F365D4-6DEE-421F-8FEE-59B5E3486C80Q37351199-F99800F7-BA40-4927-8C67-E2BE7653C937Q37432097-829160C4-0A13-4A21-AAC5-AA5F8FEDF2F3Q37457104-EBD4B979-96EE-4DB4-9D51-F81A105BC42FQ37599363-7FA5ADD1-2AC7-4D05-B8BC-2405BD34F58EQ37608845-F637CF06-8967-4C1D-A83C-06C8BD324FBEQ37979306-7B49BC5A-78E1-4D09-9B26-AC87ACD56140Q38003847-B163EE35-2D79-4169-8AFE-C7873F2E476EQ38236202-BB2DF0B8-1574-4AAA-BBA6-AAFBC0E4F573Q38306497-4F392D53-F8B6-4962-ACAA-8A444CDAF13EQ38542935-5EE82357-DC81-4293-83ED-48FD7B0B238BQ38764542-C1F49C1E-92C7-4B00-890E-950DB842A89FQ39025149-7BBC017F-F114-480B-99FD-BA06C7C07C9CQ39141759-3E91FB57-C668-4E49-88CB-226859E2E24B
P2860
N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
N-terminal peptides of stromal ...... ist and antagonist activities.
@en
type
label
N-terminal peptides of stromal ...... ist and antagonist activities.
@en
prefLabel
N-terminal peptides of stromal ...... ist and antagonist activities.
@en
P2093
P2860
P356
P1476
N-terminal peptides of stromal ...... ist and antagonist activities.
@en
P2093
Baggiolini M
Clark-Lewis I
Loetscher P
P2860
P304
22279-22283
P356
10.1074/JBC.273.35.22279
P407
P577
1998-08-01T00:00:00Z